5 benefits of a pain killer during mastitis

05-04-2018 | |
Photo: Wick Natzijl
Photo: Wick Natzijl
The addition of a pain killer (meloxicam) to standard antimicrobial therapy for clinical mastitis improves the conception rate and brings an economic benefit of € 42 per case per year. This is stated in a new research paper, published in the Journal of Dairy Science. Clinical mastitis (CM) impairs reproductive performance, including a longer interval from calving to conception, more services per conception, conception rates and a higher risk of embryo loss. The objective of this study was t


Get full access to all stories on Dairy Global

This Premium article is exclusively available for subscribers

Obtain insights from exclusive interviews

Dive into articles covering trending industry topics

Get a glimpse into dairy farms worldwide

All the news is brought to you by experienced editors and experts from around the world

Redacteur 1

Zana
van Dijk

Redacteur 2

Chris
Mccullough

Redacteur 3

Samaneh
Azarpajouh

Koeleman
Emmy Koeleman Freelance editor

Webinar-2026-CID-lines